Are diabetes drugs gender-biased?

Overweight type 2 women on exenatide/metformin therapy lose much more weight and see greater improvements across a number of parameters compared with male counterparts, say Chinese researchers.

Their study of 105 overweight or obese T2DM patients found that after six months of combination therapy, women had lost an average of 8.2kg, while male trial participants had lost only 4.6kg.

Women had